Content

Ultrasensitive Detection Technology Enabled Biomarker Discovery for Alzheimer’s Early Diagnosis

Part of the BTEC Fall 2023 Seminar Series

Friday, Sept. 29, 2023
10:40–11:30 a.m. EST
BTEC room 135

Alzheimer’s disease (AD) and related tauopathies, including progressive supranuclear palsy, corticobasal degeneration, and Pick’s disease, are characterized by intracellular tau aggregates. Using advanced technologies to develop noninvasive and less expensive tests with high sensitivity and specificity are urgent unmet needs for AD early diagnosis, disease prognosis, and tauopathy differentiation. We sought to discover and develop plasma/CSF-based or skin-based biomarkers for AD diagnosis enabled by ultrasensitive detection technologies.

Speaker

Bin Xu, Ph.D.
Principle Investigator
Biomanufacturing Research Institute & Technology Enterprise (BRITE), North Carolina Central Univeristy
Affiliated Faculty, Duke/UNC Alzheimer’s Disease Research Center